THE EFFECT OF FIRST-LINE BASED ON PLATIN AND TAXANE CHEMOTHERAPY ON DENDRITIC CELLS IN WOMEN SUFFERING FROM OVARIAN CANCER

被引：0
|
作者：
Kotarski, J. [1 ]
Wertel, I. W. I. [1 ]
Polak, G. P. G. [1 ]
机构：
[1] Med Univ Lublin, Chair & Dept Oncol Gynaecol & Gynaecol 1, Lublin, Poland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effect of bevacizumab combined with first-line chemotherapy on metastatic colorectal cancer
    Xiong, Lifeng
    Lou, Yinmei
    Wang, Lin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 3609 - 3617
  • [42] Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy
    Mayerhofer, K
    Kucera, E
    Zeisler, H
    Speiser, P
    Reinthaller, A
    Sevelda, P
    GYNECOLOGIC ONCOLOGY, 1997, 64 (01) : 109 - 113
  • [43] Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Huang, Ahong
    Wang, Li
    Baser, Onur
    Miao, Raymond
    BJU INTERNATIONAL, 2018, 121 (06) : 871 - 879
  • [44] The Cytotoxic Effect of Combined Hyperthermia and Taxane Chemotherapy on Ovarian Cancer Cells: Results of an in vitro Study
    Muller, M.
    Cherel, M.
    Dupre, P. -F.
    Gouard, S.
    Collet, M.
    Classe, J. -M.
    EUROPEAN SURGICAL RESEARCH, 2012, 48 (02) : 55 - 63
  • [45] Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study
    Correa, D. D.
    Root, J. C.
    Kryza-Lacombe, M.
    Mehta, M.
    Karimi, S.
    Hensley, M. L.
    Relkin, N.
    BRAIN IMAGING AND BEHAVIOR, 2017, 11 (06) : 1652 - 1663
  • [46] Usefulness of osteopontin (OPN) determinations in ovarian cancer patients who underwent first-line chemotherapy
    Mrochem-Kwarciak, Jolanta
    Mrochen-Domin, Izolda
    Wojcieszek, Andrzej
    Deja, Regina
    Chmura, Aleksandra
    Maslyk, Barbara
    Nowara, Elzbieta
    Kaleta, Beata
    Kolosza, Zofia
    Bartnik, Wieslawa
    GINEKOLOGIA POLSKA, 2011, 82 (12) : 911 - 917
  • [47] Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer
    Lambrechts, Sandrina
    Smeets, Dominiek
    Moisse, Matthieu
    Braicu, Elena Ioana
    Vanderstichele, Adriaan
    Zhao, Hui
    Van Nieuwenhuysen, Els
    Berns, Els
    Sehouli, Jalid
    Zeillinger, Robert
    Darb-Esfahani, Silvia
    Castillo-Tong, Dan Cacsire
    Lambrechts, Diether
    Vergote, Ignace
    EUROPEAN JOURNAL OF CANCER, 2016, 53 : 51 - 64
  • [48] Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer
    Ingle, JN
    Krook, JE
    Mailliard, JA
    Hartmann, LC
    Wieand, HS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 498 - 501
  • [49] Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer
    Robain, M
    Pierga, JY
    Jouve, M
    Asselain, B
    Diéras, V
    Beuzeboc, P
    Palangié, T
    Dorval, T
    Extra, JM
    Scholl, S
    Pouillart, P
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) : 2301 - 2312
  • [50] Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer
    Sharma, Sameer
    Rezai, Katayoun
    Driscoll, Deborah
    Odunsi, Kunle
    Lele, Shashikant
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 181 - 185
12345